SUINING, China, June 5, 2012 /PRNewswire-Asia/ -- China
Health Resource, Inc. (OTCBB: CHRI), today announced it has issued
a final termsheet to Herborium Group (OTC Pinksheets: HBRM) and is
now awaiting response from the Herborium Board of Directors.
Steve Weiss, USA Director of Strategic Acquisitions and
Financial Marketing stated, "I am most excited to have united and
introduced both CHRI with HBRM and my hope is for a favorable
outcome. As CHRI revenues continue to significantly break all time
new highs in their TCM products in China it is my hope that these products will
be introduced to all natural western markets with new domestic
distribution channels."
"We are proceeding with our Go Global Initiative which includes
setting-up headquarter operations in the USA and expansion into other key regions like
Latin America and Africa where we find opportunities to grow our
business," says Jiayin Wang, CEO of
CHRI.
Press Contact:
Mr. Steven Weiss
Contact Tel. 732-513-6921(USA)
USA Rep for China Health Resource,
Inc.
Email: info@chinahealthresource.com
www.chinahealthresource.com
About CHRI
China Health Resource, Inc. engages in the development,
manufacturing, processing, marketing and sale of raw and
pharmaceutical TCM products including Dahurian Angelica Root (DAR)
and Rhizoma Gastrodiae and is the only the provider of GAP quality
DAR in the People's Republic of
China under the registered Trademark Chuan Baizhi™. DAR,
which is also known as "Bai Zhi" in Mandarin Chinese, is an herb
that is employed as an ingredient in medicine, cosmetics and food,
as well as used in TCM for the treatment of pain, swelling and
pustule. The Company's DAR-related products include the Bailing
Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of
which are sold through regional distributors. The Company was
founded in 2001 and is based in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com.
Certain statements in this document regarding financial
matters, other than historical facts, and statements of our
expectations, intentions, plans and beliefs, constitute
"forward-looking statements" within the meaning of section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, as amended, that are subject to certain
events, risks and uncertainties that may be outside our control.
The words "believe", "expect", "anticipate", "optimistic",
"intend", "will", and similar expressions identify forward-looking
statements. The company intends that such proclamations about
future expectations, including future revenues and earnings, future
business expansion plans, and all other forward-looking statements
be subject to the safe harbors created thereby. Since these
statements involve risks and uncertainties and are subject to
change at any time, the Company's actual results may differ
materially from expected results. These and other risks and
uncertainties related to our business are described in greater
detail in our filings with the Commission. The foregoing
information should be read in conjunction with these filings. We
disclaim any intention or obligation to update or revise any
forward-looking statements. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the date on which they are made.
SOURCE China Health Resource, Inc.